Patent Number: 6,310,094

Title: Ready-to-use esmolol solution

Abstract: A ready-to-use injectable, aqueous pharmaceutical composition for the treatment of cardiac conditions, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino) propoxy] phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent and an osmotic-adjusting agent, as well as a method for its manufacture in a container, is disclosed.

Inventors: Liu; Jie (Scotch Plains, NJ), Pejaver; Satish K. (Bridgewater, NJ), Owoo; George (North Plainfield, NJ)

Assignee: Baxter International Inc.

International Classification: A61K 47/02 (20060101); A61K 31/21 (20060101); A61K 47/10 (20060101); A61K 31/24 (20060101); A61K 031/24 ()

Expiration Date: 10/30/2018